Company Ticker News February 26, 2022Vaxart: A Speculative Biotech With Potential As Covid-19 Play And Oral Vaccine Platform 0 0 Share
Company Ticker News February 25, 2022VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates 0 0 Share
Company Ticker News December 21, 2021Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine 0 0 Share
Press Release November 19, 2021Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart 0 0 Share
Company Ticker News November 5, 2021VAXART, INC. (VXRT) Reports Q3 Loss, Lags Revenue Estimates 0 0 Share
